• Tidak ada hasil yang ditemukan

https://links.lww.com/MPG/B701

N/A
N/A
Protected

Academic year: 2023

Membagikan "https://links.lww.com/MPG/B701"

Copied!
4
0
0

Teks penuh

(1)

Figure, Supplemental Digital Content 1: Flow diagram of study participants

(2)

Table, Supplemental Digital Content 2: Macronutrient reference values

Fluid Protein

(g.100ml-1)

Fat (g.100ml-1)

Carbohydrate (g.100ml-1)

Energy (kCal.100ml-1) Dextrose (Baxter, NZ)

5% 0 0 5 17

7.5% 0 0 7.5 25.5

10% 0 0 10 34

12.5 % 0 0 12.5 42.5

15% 0 0 15 51

Intravenous amino acid solutions 13

Old protocol IVN 2 0 10 42.2

New protocol IVN 3.8 0 10 49.7

New protocol IVN (<1,000 grams, <72 hours’ postnatal age, central access)

6.79 0 15 78.1

Intralipid (Fresenius Kabi AB, Uppsala, Sweden)

20% Intralipid 0 20 2.2 200

Expressed breastmilk (EBM) 36

Transitional (< day 14) 1.566 3.86 6.89 68

Mature (≥ day 14) 1.357 4.28 7.2 72

Fortifier (Nutriprem, Nutricia,

NZ) 0.8 0 3 16

Formula milk

Term infant formula (Karicare,

Nutricia, NZ) 1.5 3.8 7 68

Preterm formula (Nutriprem,

Nutricia, NZ) 2.4 4.4 7.8 80

Hydrolysed formula (Pepti-

Junior, Nutricia, NZ) 1.9 3.8 7 67

(3)

Table, Supplement Digital Content 3: Growth and anthropometry in children exposed to the old or new neonatal nutrition protocols who were assessed at 7 years

Exposed to old protocol

n = 55

Exposed to new protocol

n = 73

OR

(95% CI) P-value *Adjusted OR

(95% CI) * P-value

Growth Weight (kg)

24.26 ± 6.68 25.97 ± 6.99 1.71 (-0.81 – 4.24)

0.18 1.46 (-0.94 – 3.86)

0.23 Weight z-score

-0.11 ± 1.47 0.37 ± 1.38 0.48 (-0.04 – 1.00)

0.07 0.41 (-0.08 – 0.90)

0.10 Height (cm)

122.7 ± 5.8 124.4 ± 6.1 1.7 (-0.5 – 3.9)

0.13 1.5 (-0.7 – 3.6) 0.19 Height z-score

0.02 ± 1.02 0.34 ± 1.16 0.33 (-0.08 – 0.73)

0.11 0.29 (-0.11 – 0.69)

0.15 Leg length (cm)

55.5 ± 3.3 56.3 ± 3.5 0.8 (-0.5 – 2.1)

0.22 0.6 (-0.6 – 1.9) 0.32 Leg length z-score

-0.35 ± 0.99 -0.11 ± 1.14 0.24 (-0.16 – 0.64)

0.24 0.21 (-0.18 – 0.61)

0.29 Sitting height (cm)

67.2 ± 3.4 68.0 ± 3.1 0.8 (-0.4 – 2.0)

0.20 0.7 (-0.5 – 1.9) 0.27 Sitting height z-

score 0.40 ± 1.07 0.63 ± 1.03 0.23 (-0.16 –

0.62)

0.25 0.23 (-0.17 – 0.62)

0.26 Head

circumference (cm)

51.7 ± 1.7 51.9 ± 2.1 0.2 (-0.5 – 0.8)

0.59

0.0 (-0.6 – 0.7)

0.92

Head

circumference z- score

-1.10 ± 1.13 -0.98 ± 1.57 0.13 (-0.34 – 0.59)

0.60 0.06 (-0.41 – 0.52)

0.81

Body Mass Index

(BMI) (kg.m-2) 15.9 ± 3.1 16.6 ± 3.2 0.7 (-0.5 –

1.9) 0.23 0.6 (-0.5 – 1.7) 0.29

BMI z-score -0.18 ± 1.49 0.25 ± 1.37 0.43 (-0.09 – 0.95)

0.10 0.36 (-0.12 – 0.85)

0.14 Abnormal BMI

15 (27%) 19 (26%) 0.94 (0.42 – 2.11)

0.88 0.93 (0.42 – 2.07)

0.85

Obese 3 (5%) 7 (10%) - -

Overweight 8 (15%) 11 (15%) - -

Thin 4 (7%) 1 (1%) - -

Abdominal circumference (cm)

56.8 ± 8.0 58.5 ± 9.1 1.7 (-1.5 –

4.9) 0.31 1.5 (-1.6 – 4.5) 0.34

(4)

Abdominal circumference z-score

0.53 ± 1.49 0.86 ± 1.39 0.33 (-0.20 –

0.85) 0.22 0.29 (-0.20 –

0.78) 0.25

Waist: height ratio 0.46 ± 0.05 0.47 ± 0.06 0.01 (-0.01 –

0.03) 0.48 0.01(-0.01 –

0.03) 0.51

Change in z-scores (birth to age 7)

Weight -0.21

(-0.98–0.80)

0.16 (-0.65 – 1.01)

0.40 (-0.12 –

0.93) 0.14 0.41 (-0.08 –

0.90) 0.10

Height 0.11 ± 1.31 0.30 ± 1.37 0.19 (-0.30 –

0.68) 0.45 0.21 (-0.25 –

0.67) 0.37

Head

circumference -1.41 ± 1.33 -1.14 ± 1.56 0.28 (-0.24 –

0.79) 0.29 0.24 (-0.23 –

0.72) 0.32

Body composition n = 53 n = 71

Fat mass (kg) 4.78 ± 4.14 5.48 ± 4.72 0.70 (-0.98 –

2.37) 0.42 0.65 (-0.95 –

2.24) 0.43

Fat mass, adjusted for height and lean mass#

5.26 ± 0.43 5.12 ± 0.38 -0.14 (-1.29 –

1.01) 0.82 0.13 (-0.90 –

1.16) 0.81

Android/gynoid fat

ratio 0.30 ± 0.11 0.32 ± 0.11 0.02 (-0.02 –

0.06) 0.26 0.01(-0.01 –

0.06) 0.21

Lean mass (kg) 18.42 ± 2.92 19.09 ± 2.87 0.67 (-0.39 –

1.73) 0.22 0.37 (-0.59 –

1.32) 0.45

Height adjusted

lean mass# 18.84 ± 0.24 18.78 ± 0.21 -0.06 (-0.73 –

0.61) 0.86 -0.19 (-0.79 –

0.41) 0.53

Bone mineral density (g.cm-3)

0.67 ± 0.06 0.69 ± 0.05 0.02 (-0.00 –

0.04) 0.06 0.02(-0.00 –

0.04) 0.10

Height adjusted bone mineral density#

0.68 ± 0.01 0.69 ± 0.01 0.01(-0.01 –

0.03) 0.27 0.01(-0.01 –

0.02) 0.30

Central fatness (android fat mass, adjusted for height, lean mass and gynoid fat mass) #

412 ± 13 437 ± 11 25.13 (-9.25 –

59.51) 0.15 26.76 (-8.22 –

61.74) 0.13

Data are n (%), mean ± SD, median (IQR), odds ratio or mean difference (95% CI), or # Standard regression-adjusted mean ± (SE). Children exposed to the old protocol is the reference group.

* Adjusted for sex and birthweight z-score

Referensi

Dokumen terkait

Supplemental Digital Content 3: Correlation between microbiota richness Chao1 and diversity Shannon Index and children’s body composition Fat Mass Index FMI and Fat Free Mass Index FFMI

Supplemental Digital Content 6 GMT for HI antibodies pre-vaccination and 7 days after first vaccination in the revaccination study in children 30−48 months of age per-protocol cohort

Supplemental digital content Table: Socio-demographic and clinical characteristics of children at enrollment in care Characteristics at enrollment in care n %* Gender Male 229 52%

BMI, body mass index; CNR, contrast-to-noise ratio; HU, Hounsfield unit; SNR, signal-to- noise ratio Supplemental Digital Content

SUPPLEMENTAL DIGITAL CONTENT, FIGURE LEGEND Supplemental Digital Content, FIGURE 1.Video head-impulse test vHIT, cVEMP and oVEMP recordings during the second hBPPV event right

Supplemental Digital Content Overview of characteristics and main findings of included studies on exercise performance over the menstrual cycle Reference Participants Exclusion

Supplemental Digital Content Table 1: Demographic, preoperative and postoperative characteristics of cases undergoing DSAEK after TASS Cas e

PRELINGUISTIC VOCAL DEVELOPMENT IN CHILDREN WITH CI 1 Supplemental Digital Content 4 Participant Characteristics and Quality Indicators of Included Studies Sample Reference n n